ClinicalTrials.Veeva

Menu

Prospective Memory Imaging (IMPRO)

C

Caen University Hospital

Status

Unknown

Conditions

Alzheimer Disease

Treatments

Other: Functional MRI
Other: Structural MRI
Other: Virtual reality / Memory assessment
Behavioral: Memory assessment

Study type

Interventional

Funder types

Other

Identifiers

NCT01638884
2010-A00031-38

Details and patient eligibility

About

The purpose of this study is to investigate prospective merory (memory of intentions) in healthy controls and in aMCI (amnestic Mild Cognitive Impairment) and AD (Alzheimer Disease) patients.

Enrollment

118 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria :

  • Education level > 7 years

  • Native language: French

  • Beck < 7

  • Medical, neurological, neuropsychological and neuroradiological depth in accordance with the criteria for inclusion and exclusion-specific population, that is to say:

    • Young Healthy Subjects: between 18 and 44 years old;
    • Middle age Healthy Subjects: between 45 and 69 years old; without memory complaints, normal performances compared to the age and the educational level for all tests of the diagnostic battery.
    • Elderly Healthy Subjects: over 70 years old, without memory complaints, normal performances compared to the age and the educational level for all tests of the diagnostic battery.
    • MCI patients: over 50 years old, presenting the current criteria for amnestic MCI including: i) memory complaint, ii) deficits of the episodic memory (lower performance of at least 1 SD from the norm for age and cultural level for one or more scores of episodic memory and iii) normal performances compared to the age and the educational level of all other cognitive functions as memory, including tests to assess cognitive abilities.
    • Alzheimer's patients: over 50 years old, presenting the standard criteria of NINCDS-ADRDA probable Alzheimer's disease, including abnormal global cognitive function and deficits in at least two cognitive domains identified by the diagnostic battery and a mild to moderate Alzheimer's disease (MMSE ≥ 18).

Exclusion Criteria :

  • The sudden onset of cognitive impairments (as opposed to their slow and gradual installation in Alzheimer's disease)
  • A chronic neurological, psychiatric, endocrine, hepatic or infectious complaint
  • A history of major disease (a lung, heart, metabolic, hematologic, endocrine disease or a severe cancer);
  • A medication that may interfere with memory or metabolic measures
  • A alcohol or drugs abuse
  • claustrophobia, metallic object in the body
  • A predominantly left-hand (score below 50% in Edinburgh Inventory).
  • Protected adults, and persons not affiliated with a social security system will not participate in this study.
  • Pregnant or suckling women
  • The inclusion of a participant in another biomedical research protocol (during the study or within 12 months before inclusion)

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

118 participants in 5 patient groups

Young Healthy Subjects
Experimental group
Treatment:
Other: Virtual reality / Memory assessment
Other: Functional MRI
Other: Structural MRI
Behavioral: Memory assessment
Middle age Healthy Subjects
Experimental group
Treatment:
Other: Virtual reality / Memory assessment
Other: Functional MRI
Other: Structural MRI
Behavioral: Memory assessment
Elderly Healthy Subjects
Experimental group
Treatment:
Other: Virtual reality / Memory assessment
Other: Functional MRI
Other: Structural MRI
Behavioral: Memory assessment
Mild Cognitive Impairment patients
Experimental group
Treatment:
Other: Virtual reality / Memory assessment
Other: Functional MRI
Other: Structural MRI
Behavioral: Memory assessment
Alzheimer Disease patients
Experimental group
Treatment:
Other: Virtual reality / Memory assessment
Other: Functional MRI
Other: Structural MRI
Behavioral: Memory assessment

Trial contacts and locations

3

Loading...

Central trial contact

Julien Chavant

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems